نتایج جستجو برای: clavolanic acid and cefoxitin cefoxitin

تعداد نتایج: 16938775  

Journal: :Journal of clinical microbiology 1987
A L Barry R N Jones

Tests with 2,713 bacterial isolates (members of the family Enterobacteriaceae and gram-positive cocci) from 14 laboratories compared cefoxitin MICs with cefotetan MICs. Strains that were susceptible to cefoxitin could be assumed to be susceptible to cefotetan. Over half of the cefoxitin-resistant isolates of the Enterobacteriaceae were susceptible to cefotetan.

Journal: :Current Microbiology 2021

One of the mechanisms Klebsiella pneumoniae and Escherichia coli resistance to ?-lactam antibiotics is production ?-lactamase enzymes. Among these are AmpC ?-lactamases, which confer a class antibiotics. However, little known about ?-lactamases K. E. clinical isolates in Qazvin, Iran. This study was designed assess ??lactamases-producing strains also identify prevalence ??lactamases genes. Anti...

Journal: :Antimicrobial agents and chemotherapy 1982
R E Bawdon D L Hemsell S P Guss

Cefoperazone and cefoxitin concentrations were determined in serum and pelvic tissue samples obtained at various intervals after a 2-g intramuscular dose. These levels were determined in 59 women scheduled for elective abdominal hysterectomy. Concentrations were measured by a new high-pressure liquid chromatography method which correlated with the microbiological assay. The mean times (+/- stan...

Journal: :Antimicrobial agents and chemotherapy 1981
W L Greaves J H Kreeft R I Ogilvie G K Richards

The pharmacokinetic disposition of 2 g of cefoxitin administered intravenously over 30 min was determined in six patients undergoing continuous ambulatory peritoneal dialysis for chronic renal failure. During the 6-h dialysate dwell time after the drug infusion, the mean apparent volume of distribution for cefoxitin was 0.267 liter/kg (range, 0.201 to 0.325 liter/kg), and the mean elimination t...

Journal: :Antimicrobial agents and chemotherapy 2014
H Guet-Revillet A Emirian M Groh B Nebbad-Lechani E Weiss O Join-Lambert E Bille V Jullien J R Zahar

Cefoxitin could be an alternative to carbapenems in extended-spectrum-beta-lactamase-producing Escherichia coli (ESBL-EC) infections. However, pharmacological and clinical data regarding cefoxitin are limited. Using a recent pharmacological model and the MICs of ESBL-EC collected from pyelonephritis, we determined the probabilities to reach four pharmacological targets: free cefoxitin concentra...

Journal: :The Journal of Chemical Thermodynamics 2016

Journal: :Antimicrobial agents and chemotherapy 1974
H R Onishi D R Daoust S B Zimmerman D Hendlin E O Stapley

Cefoxitin is a new, cephalosporin-like antibiotic which is highly resistant to hydrolysis by beta-lactamase. Ninety-one cultures were selected either for their general resistance to cephalosporin antibiotics or for their ability to produce beta-lactamase. Some of these cultures were resistant to cefoxitin. The capacity of each of the 91 strains to hydrolyze cefoxitin with beta-lactamase was det...

Journal: :Journal of clinical and diagnostic research : JCDR 2014
D L Maraskolhe V S Deotale D K Mendiratta P Narang

BACKGROUND AND OBJECTIVE AmpC β lactamases are one of the important causes of drug resistance in gram negative bacteria. Failure to detect these enzymes in the laboratory has contributed to therapeutic failures but there are till date no standard guideline available. This study was therefore undertaken to evaluate three phenotypic laboratory tests and the inhibitors used in two of the tests to ...

Introduction: In this study, using the phenotypic and genotypic methods, oxacillin susceptibility in Staphylococcus aureus (S. aureus) strains isolated from patients at two government hospitals in Ilam, Iran was tested. Materials and methods: Out of 200 S. aureus isolates from different human clinical specimens consisting of blood (31%), wound (20%), urine (21%), catheters (7%), sputum (12...

Journal: :Antimicrobial agents and chemotherapy 1986
R V McCloskey

The objective of this double-blind study was to compare the efficacy and safety of piperacillin with that of cefoxitin in patients with bacterial infections. Seventy hospitalized patients were treated with intravenous piperacillin (18 g/day) or cefoxitin (12 g/day) for a mean period of 11.5 days. Multiple serious underlying conditions were present in 91% of the patients in both treatment groups...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید